University of Kentucky Markey Cancer Center researchers identified a protein that could be key to developing new treatments ...
Keytruda in early-stage triple-negative breast cancer led to immune-related adverse effects, including severe GI issues and ...
Breast cancer patients have been given fresh hope after a new vaccine showed "promise" in treating an aggressive form of the ...
Cleveland Clinic researchers are presenting updated findings from their novel study of a vaccine aimed at preventing triple-negative breast cancer, the most aggressive and lethal form of the disease.
Cleveland Clinic researchers are presenting updated findings from their novel study of a vaccine aimed at preventing ...
An expert told CURE that Trodelvy's side effects, such as neutropenia and fatigue, can often be managed through dose ...
University of Kentucky Markey Cancer Center researchers identified a protein that could be key to developing new treatments ...
Cleveland Clinic researchers are presenting updated findings from their novel study of a vaccine aimed at preventing ...
Plan to announce initial clinical data for XMT-1660 at a company event by the end of 2024 Dose escalation advancing in Phase ...
A vaccine against triple-negative breast cancer was found to produce an immune response and was well tolerated by most patients during an ongoing clinical trial. The findings will be presented by ...